Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian R Long

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Stem Cell Reports|January 4, 2016
Fetal Hematopoietic Stem Cell Transplantation Fails to Fully Regenerate the B-Lymphocyte CompartmentEliver Eid Bou Ghosn, Jeffrey Waters, Megan Phillips, et al.
Blood|October 7, 2009
Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4Jeffrey M Milush, Brian R Long, Jennifer E Snyder-Cappione, et al.
Clinical and Vaccine Immunology : CVI|November 16, 2007
Elevated frequency of gamma interferon-producing NK cells in healthy adults vaccinated against influenza virusBrian R Long, Jakob Michaelsson, Christopher P Loo, et al.
Molecular Therapy. Methods & Clinical Development|June 14, 2019
The Impact of Pre-existing Immunity on the Non-clinical Pharmacodynamics of AAV5-Based Gene TherapyBrian R Long, Krystal Sandza, Jennifer Holcomb, et al.
Blood|March 3, 2012
Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicityLishomwa C Ndhlovu, Sandra Lopez-Vergès, Jason D Barbour, et al.
Plos One|October 25, 2007
HIV-1/HSV-2 co-infected adults in early HIV-1 infection have elevated CD4+ T cell countsJason D Barbour, Mariana M Sauer, Elizabeth R Sharp, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2020
Early Phase Clinical Immunogenicity of Valoctocogene Roxaparvovec, an AAV5-Mediated Gene Therapy for Hemophilia ABrian R Long, Philippe Veron, Klaudia Kuranda, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 26, 2024
Clinical immunogenicity outcomes from GENEr8-1, a phase 3 study of valoctocogene roxaparvovec, an AAV5-vectored gene therapy for hemophilia ABrian R Long, Tara M Robinson, Jonathan R S Day, et al.
Immunology|October 15, 2009
Increased number and function of natural killer cells in human immunodeficiency virus 1-positive subjects co-infected with herpes simplex virus 2Brian R Long, Ann E Erickson, Joan M Chapman, et al.
Virology|June 28, 2014
Efficacy of broadly neutralizing monoclonal antibody PG16 in HIV-infected humanized miceCheryl A Stoddart, Sofiya A Galkina, Pheroze Joshi, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Stem Cell Reports|January 4, 2016
Fetal Hematopoietic Stem Cell Transplantation Fails to Fully Regenerate the B-Lymphocyte CompartmentEliver Eid Bou Ghosn, Jeffrey Waters, Megan Phillips, et al.
Blood|October 7, 2009
Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4Jeffrey M Milush, Brian R Long, Jennifer E Snyder-Cappione, et al.
Clinical and Vaccine Immunology : CVI|November 16, 2007
Elevated frequency of gamma interferon-producing NK cells in healthy adults vaccinated against influenza virusBrian R Long, Jakob Michaelsson, Christopher P Loo, et al.
Molecular Therapy. Methods & Clinical Development|June 14, 2019
The Impact of Pre-existing Immunity on the Non-clinical Pharmacodynamics of AAV5-Based Gene TherapyBrian R Long, Krystal Sandza, Jennifer Holcomb, et al.
Blood|March 3, 2012
Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicityLishomwa C Ndhlovu, Sandra Lopez-Vergès, Jason D Barbour, et al.
Plos One|October 25, 2007
HIV-1/HSV-2 co-infected adults in early HIV-1 infection have elevated CD4+ T cell countsJason D Barbour, Mariana M Sauer, Elizabeth R Sharp, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2020
Early Phase Clinical Immunogenicity of Valoctocogene Roxaparvovec, an AAV5-Mediated Gene Therapy for Hemophilia ABrian R Long, Philippe Veron, Klaudia Kuranda, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 26, 2024
Clinical immunogenicity outcomes from GENEr8-1, a phase 3 study of valoctocogene roxaparvovec, an AAV5-vectored gene therapy for hemophilia ABrian R Long, Tara M Robinson, Jonathan R S Day, et al.
Immunology|October 15, 2009
Increased number and function of natural killer cells in human immunodeficiency virus 1-positive subjects co-infected with herpes simplex virus 2Brian R Long, Ann E Erickson, Joan M Chapman, et al.
Virology|June 28, 2014
Efficacy of broadly neutralizing monoclonal antibody PG16 in HIV-infected humanized miceCheryl A Stoddart, Sofiya A Galkina, Pheroze Joshi, et al.
Pageof 4